Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

04/20/07 No Generic Substitution of AEDs (anti seizure drugs) Without Physician and Patient Consent, Says AAN        

04/19/07 Race for Hope - Washington, DC May 6, 2007        

04/19/07 Data From Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting        

04/18/07 Bothell biotech sees opportunity in Switzerland - Northwest Biotherapeutics wants to sell its brain cancer treatment, currently in clinical trials in the U.S., in the European nation.        

04/18/07 Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).        

04/18/07 A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.        

04/18/07 Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.        

04/18/07 Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.        

04/18/07 Establishment of experimental glioma models at the intrinsic brainstem region of the rats.        

04/18/07 Risk of malignancy after gamma knife stereotactic radiosurgery.        

04/18/07 Gamma knife surgery for focal brainstem gliomas.        

04/18/07 Canadian robot melds brain surgery, rocket science        

04/18/07 Data Presented at AACR Meeting Show Peregrine's Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer        

04/18/07 Epidemiology of venous thromboembolism in 9489 patients with malignant glioma.        

04/18/07 Myriad Genetics Presents Azixa's Mode of Action at AACR        

04/18/07 NICE finally approves glioma drugs after finding error in its calculations        

04/18/07 YM BioSciences' partner Daiichi Sankyo receives clearance for initial clinical trial in Japan        

04/18/07 Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR Annual Meeting 2007        

04/18/07 A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.        

---

Displaying Stories 3921 to 3940 of 7673
Previous 20           Next 20